These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 13409061)

  • 1. BZ 55 and D 860 in the treatment of diabetes mellitus.
    SCHNEIDER T; POLITZER WM
    S Afr Med J; 1957 Feb; 31(7):142-6. PubMed ID: 13409061
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical use of oral sulfonylurea compounds in diabetes mellitus.
    COLWELL AR; COLWELL JA
    Q Bull Northwest Univ Med Sch; 1957; 31(2):102-13. PubMed ID: 13453644
    [No Abstract]   [Full Text] [Related]  

  • 3. CARBUTAMIDE and tolbutamide in diabetes.
    S Afr Med J; 1956 Dec; 30(51):1221-2. PubMed ID: 13391101
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diabetes mellitus, BZ 55, D 860, and glucagon].
    RECKNAGEL K
    Medizinische; 1956 Nov; 1(46):1633-9. PubMed ID: 13386740
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment for diabetes with sulfamide hypoglycemic agents].
    DEUIL R
    Rev Prat; 1956 Dec; 6(33):3687-94. PubMed ID: 13408836
    [No Abstract]   [Full Text] [Related]  

  • 6. BZ 55 in diabetes.
    MCKENZIE JM; MARSHALL PB; STOWERS JM; HUNTER RB
    Br Med J; 1956 Aug; 2(4990):448-51. PubMed ID: 13342510
    [No Abstract]   [Full Text] [Related]  

  • 7. [BZ 55 and D 860 in therapy of diabetes mellitus].
    BALDUINI M; BOARI L
    Boll Soc Med Chir Cremona; 1956; 11(1):37-53. PubMed ID: 13412973
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of BZ 55 in control of diabetes.
    MURRAY I; WANG I
    Br Med J; 1956 Aug; 2(4990):452-4. PubMed ID: 13342512
    [No Abstract]   [Full Text] [Related]  

  • 9. [BZ 55 of D 860 as oral antidiabetic].
    MEHNERT B; MEHNERT H
    Munch Med Wochenschr; 1956 Sep; 98(39):1325-8. PubMed ID: 13378442
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences on 1,000 diabetics treated with sulfonylureas (BZ 55 and D 860)].
    BERTRAM F
    Gaz Med Fr; 1957 Mar; 64(6):519-24. PubMed ID: 13427958
    [No Abstract]   [Full Text] [Related]  

  • 11. [D 860 (rastinon) and BZ 55 (invenol) in oral therapy of diabetes mellitus].
    MELZER H; SACHSSE B
    Arztl Wochensch; 1956 Nov; 11(48):1058-62. PubMed ID: 13394470
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical comparison of carbutamide (BZ 55) and tolbutamide (D 860) treatment of diabetes mellitus; preliminary results of a combined therapy with both drugs].
    INTROZZI P; MARIGO S
    Prog Med (Napoli); 1957 Feb; 13(3):65-72. PubMed ID: 13420208
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trial of the new oral hypoglycaemic agent BZ 55.
    HUNT JA; OAKLEY W; LAWRENCE RD
    Br Med J; 1956 Aug; 2(4990):445-8. PubMed ID: 13342509
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of new hypoglycemizing sulfonamides; BZ 55 and D 680; 20 case reports].
    HERBEUVAL R; CUNY G; LARCAN A
    Rev Med Nancy; 1957 Mar; 82():257-64. PubMed ID: 13442233
    [No Abstract]   [Full Text] [Related]  

  • 15. [The current place of hypoglycemic sulfonamides (BZ 55) and similar products (D 860) in diabetic control].
    BASTENIE PA
    Brux Med; 1957 Mar; 37(13):499-506. PubMed ID: 13426651
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of carbutamide (BZ-55) and orinase (D860) in the treatment of diabetes mellitus.
    SHEPPE WM
    W V Med J; 1957 Feb; 53(2):70-3. PubMed ID: 13401692
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current status of oral diabetic therapy; clinical investigations with BZ 55 and D 860].
    BERTRAM F; BENDFELDT E; OTTO H
    Schweiz Med Wochenschr; 1957 Jan; 87(2):25-30. PubMed ID: 13408949
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolbutamide in treatment of diabetes mellitus.
    BUTTERFIELD WJ; FRY IK; HARDWICK C; HOLLING HE
    Br Med J; 1957 Aug; 2(5040):325-7. PubMed ID: 13446469
    [No Abstract]   [Full Text] [Related]  

  • 19. The mechanism of action of the sulfonylureas in diabetes mellitus.
    LEVINE R; SOBEL GW
    Diabetes; 1957; 6(3):263-9. PubMed ID: 13427633
    [No Abstract]   [Full Text] [Related]  

  • 20. Current status of aryl sulfonylureas in treatment of diabetes mellitus.
    DAVIDSON JW; UNGER RH
    J Am Med Assoc; 1956 Sep; 162(5):447-53. PubMed ID: 13357329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.